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716a Wednesday, February 24, 2010(DpCa50=0.0850.02), while no significant difference was present in sham
hearts (DpCa50=0.0150.02).
These measurements indicate that economy of myofilament contraction is re-
duced in post-MI remodeled myocardium.
3723-Pos
Myosin Heavy Chain Isoform Expression and Contractile Function in
Mechanically Unloaded Left Ventricles Following Left Ventricular Assist
Device (LVAD) Implantation
Matthew R. Locher, Holly S. Norman, Satoru Osaki, Takushi Kohmoto,
Nancy K. Sweitzer, Richard L. Moss.
University of Wisconsin Madison, Madison, WI, USA.
The ventricles of human myocardium normally express low levels of a myosin
heavy chain (MHC) on a predominately bMHC background. However, in heart
failure the distribution changes to ~100% b MHC with virtually undetectable
levels of aMHC, a change that has been associatedwith contractile dysfunction.
In cases of severe failure, surgical implantation of a left ventricular assist device
(LVAD) may be used as destination therapy and has been previously associated
with improvements in contractile function in single myocytes. Here, we used
post-LVADmyocardium in which the heart has been explanted for transplanta-
tion to test the hypothesis that mechanical unloading of ventricular myocardium
increases contraction kinetics, possibly through the re-expression of a MHC.
Measurements of themaximal rate of ATP utilization and isometric force in per-
meabilizedmulticellular preparations revealed no significant difference between
failing myocardium prior to LVAD implantation (pre-LVAD) and post-LVAD
myocardium. Tension cost, which is calculated as the rate of ATP utilization di-
vided by the isometric force, was also similar between groups. For comparison,
normalmyocardiumdisplayedmaximal rates of ATP turnover that were approx-
imately 2.5-fold greater than in pre- and post-LVAD myocardium. SDS-PAGE
indicated virtually undetectable levels of aMHC in pre- and post-LVAD myo-
cardium, while protein phosphorylation gels revealed significant differences in
the basal level of phosphorylation of myosin binding protein-C, TnT, and TnI
between both groups. These results suggest that while mechanical unloading
of failing myocardiummay not cause a re-expression of aMHC, improvements
in contractile function following LVAD implantation may be associated in part
with alterations in the phosphorylation status of key regulatory proteins. This
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In this study we investigated the postnatal developmental changes in sarcomeric
protein expression in parallel with contractile parameters in myofibrils isolated
from small resections from the right ventricular (RV) outflow tract in 25 patients
with Tetralogy of Fallot and related congenital heart diseases (CHD). These
CHDs are associated with RV hypertrophy and outflow tract obstruction. The
age of the patients ranged from 4 days to 38 months. The resections were pro-
cured during surgical correction of the cardiac malformation and would have
been otherwise discarded. In the neonate (4 days old), the expression of slow
skeletal TnI (ssTnI) and atrial light chain (ALC-1) was ~82% and ~50% respec-
tively and declined to respectively< ~8% and ~3% at the age of 38months. This
down-regulation in ssTnI and ALC-1 expression correlated (p<0.05) with the
decline in Ca2þ-sensitivity from pCa50 ¼ 5.95 in the neonate to pCa50 ¼ 5.33
in 38 months old infants. Neither contraction nor relaxation kinetics correlated
with ssTnI expression. However, ALC-1 expression correlated positively with
the activation kinetics, kACT and force redevelopment, kTR (r ¼ 0.62, p<0.05).
The time course of relaxation is biphasic with an initial slow quasi-linear decay
followed by a fast exponential decay. The rate constant of the fast exponential
decay, kREL correlated positively with ALC-1 expression (r ¼ 0.57, p<0.05).
In summary right ventricular hypertrophy associated with congenital heart dis-
ease does not prevent the developmental down-regulation of ssTnI and ALC-1
although we cannot exclude that this down-regulation occurs at a slower rate
than in healthy infants. The change in ssTnI expression correlates with the ex-
pected decrease in Ca2þ-sensitivity while ALC-1 expression appears to modu-
late crossbridge turnover kinetics in agreement with studies in animals.
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Male mice expressing an autosomal dominant mutation in alpha-myosin heavy
chain (R403Q) develop hypertrophic cardiomyopathy characterized by pro-gressive left-ventricular dilation and cardiac dysfunction whereas females do
not. We wished to determine whether these sex dimorphisms were due to un-
derlying differences in myofilament contractile function. Therefore, we deter-
mined the sensitivity of the myofilaments to Ca2þ in demembranated cardiac
trabeculae (CT) from wild-type (WT) and R403Q male and female mice
(10-12 months of age). We demonstrate that the R403Q mutation did not affect
Ca2þ-sensitive tension development in CT from males. While Ca2þ-sensitivity
was greater in both male WT and R403Q CT compared to WT females, they
were less sensitive to Ca2þ than CT from female R403Q hearts. We also deter-
mined rates of tension redevelopment (ktr) following a release-restretch proto-
col in CT from WT and R403Q male and female hearts at the same age. CT
from R403Q male hearts exhibited an enhanced ktr compared to WT males.
The ktr in WT female CT was similar to WT males. The ktr in R403Q female
CT measured between WT and R403Q males. We hypothesized that the sex di-
morphisms in myofialment function reflect an increase in the energetic cost of
contraction when expressing the R403Q mutation. Therefore, we measured
levels of Adenosine monophosphate-activated kinase (AMPK), a central sensor
of the cellular energy state. Total AMPK protein levels were significantly in-
creased in 10-12 month male R403Q hearts compared to WT controls. Female
R403Q hearts showed the opposite: total AMPKa expression was lower com-
pared to WT controls. We conclude that (1) the increased Ca2þ-sensitivity may
provide sufficient contractile support in female R403Q hearts maintaining
a compensated state, and (2) the increased AMPK expression in male R403Q
hearts is indicative of an increased energetic demand caused by the mutation.
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Female mouse hearts show better functional recovery after ischemia/reperfusion
(I/R) injury comparedwithmales.However, the vulnerability of isolated late preg-
nant (LP)hearts to I/R injury is unknown.Herewe investigated the susceptibility of
isolatedmouse hearts in LP andpostpartum(PP) to I/R injury. Isolated hearts (Lan-
gendorff) from femalemice in diestrus stage (NP), LP, one day PP (PP1) and 7 day
PP (PP7) were subjected to 20 minutes of global normothermic (37C) ischemia
followedby40minutes of reperfusion.Theheart functionwas recorded throughout
the experiments and infarct size was assessed by triphenyltetrazolium staining at
the end of reperfusion. Although the function was similar in all 4 groups before
ischemia, the functional recovery of LP hearts at the end of reperfusion was
significantly lower compared to NP hearts; the rate pressure product (RPP) was
reduced from 1292651479mmHg*beats/min in NP to 16145438mmHg*beats/
min in LP mice. Interestingly, the RPP recovered partially in PP1 to
47165584mmHg*beats/min and almost fully back to NP levels one week PP.
Consistent with the functional recovery findings, the infarct size was markedly
larger in LP (59.755.2%) compared with NP (15.250.8%). The infarct size
was restored partially in PP1 and fully back in PP7. Recently we have observed
that Intralipid can protect the malemouse heart against I/R injury. To test whether
Intralipid can improve the heart function in LPmice, 1% Intralipid was applied to
isolated LP hearts at the onset of reperfusion. Intralipid treatment significantly im-
proved the cardiac function of LP mice (RPP=1156551599mmHg*beats/min)
and reduced the infarct size (1751.1%) to similar values as in NP. In conclusion,
isolatedLP hearts have high vulnerability to I/R injury and postischemic treatment
with Intralipid can protect the heart against I/R injury.
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Acute myocardial infarction is a major cause of mortality, and the best hope of
salvaging viable myocardium is by rapid cardiac reperfusion. A novel cardio-
protective drug which could be applied at the time of reperfusion after acute
infarction would be ideal. Here we tested the hypothesis that administration
of Intralipid at the onset of reperfusion protects the heart against ischemia re-
perfusion (I/R) injury. Isolated hearts (Langendorff) from male mice were sub-
jected to 20 minutes of global normothermic (37C) ischemia followed by 40
minutes of reperfusion with Krebs Henseleit buffer (CTRL) or with additional
1% Intralipid (ILP). Postischemic treatment with Intralipid significantly im-
proved the cardiac function; the rate pressure product (RPP) was increased
from 34325334mmHg*beats/min in CTRL to 1540551011mmHg*beats/
min in ILP. Consistent with the higher functional recovery in ILP, the infarct
